Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 16651-16700 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT03777384
EValuating the Safety of De-escaLated Head and Neck Irradiation in HPV PositivE Oropharynx Cancer in Non-smokers/minimal Smokers
N/A
Active, not recruiting
75 participants
Started: Oct 12, 2018 · Completed: Dec 31, 2026
1 condition
1 sponsor
2 locations
NCT03264131
BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma
PHASE2
Active, not recruiting
16 participants
Started: Oct 11, 2018 · Completed: Dec 15, 2028
3 conditions
2 sponsors
4 locations
NCT03729518
TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck
NA
Active, not recruiting
150 participants
Started: Oct 11, 2018 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT04714866
Cognitive Behavioral Therapy for University Students Diagnosed With Attention-deficit Hyperactivity Disorder (ADHD)
NA
Active, not recruiting
65 participants
Started: Oct 11, 2018 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT03997162
Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric Cancer Undergoing Surgery
N/A
Active, not recruiting
52 participants
Started: Oct 11, 2018 · Completed: Feb 4, 2026
18 conditions
2 sponsors
1 location
NCT03689699
Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)
PHASE1/PHASE2
Active, not recruiting
59 participants
Started: Oct 11, 2018 · Completed: Jan 31, 2026
2 conditions
2 sponsors
4 locations
NCT03759431
Vocal-cord vs. Complete Laryngeal Radiotherapy for Early Glottic Cancer
PHASE2
Active, not recruiting
155 participants
Started: Oct 11, 2018 · Completed: Dec 12, 2026
3 conditions
3 sponsors
3 locations
NCT06190600
Supervised Physical Activity in Young Women With Early Breast Cancer During Neoadjuvant Chemotherpy
NA
Active, not recruiting
40 participants
Started: Oct 11, 2018 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04081428
Using Breath, Cell Free DNA and Image Analysis to PRedIct Normal TissUe and Tumour Response During Prostate Cancer SBRT
N/A
Active, not recruiting
60 participants
Started: Oct 11, 2018 · Completed: Jan 11, 2026
4 conditions
1 sponsor
1 location
NCT03602859
A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer
PHASE3
Active, not recruiting
1,402 participants
Started: Oct 11, 2018 · Completed: Jun 22, 2026
2 conditions
2 sponsors
180 locations
NCT03624673
Endoscopic Robot-Assisted Simple Enucleation Versus Standard Robot-Assisted Partial Nephrectomy in the Treatment of T1 Renal Cell Carcinoma
NA
Active, not recruiting
380 participants
Started: Oct 11, 2018 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT03249207
SC IL-1Ra in SAH - Phase III Trial (SCIL)
PHASE3
Active, not recruiting
612 participants
Started: Oct 11, 2018 · Completed: Sep 30, 2024
1 condition
4 sponsors
17 locations
NCT03616587
Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer.
PHASE1
Active, not recruiting
396 participants
Started: Oct 11, 2018 · Completed: Dec 31, 2026
1 condition
1 sponsor
17 locations
NCT03603795
Study Impact on Outcome of Eltrombopag in Elderly Patients with Acute Myeloid Leukemia Receiving Induction Chemotherapy
PHASE2
Active, not recruiting
110 participants
Started: Oct 11, 2018 · Completed: Jul 30, 2026
1 condition
2 sponsors
15 locations
NCT03418467
Risk Factors in Tachycardiomyopathy
N/A
Active, not recruiting
60 participants
Started: Oct 11, 2018 · Completed: May 31, 2030
3 conditions
1 sponsor
1 location
NCT03576417
A Trial Evaluating the Addition of Nivolumab to Cisplatin-RT for Treatment of Cancers of the Head and Neck
PHASE3
Active, not recruiting
680 participants
Started: Oct 10, 2018 · Completed: Sep 30, 2027
1 condition
3 sponsors
1 location
NCT03539536
Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer
PHASE2
Active, not recruiting
270 participants
Started: Oct 10, 2018 · Completed: Aug 31, 2026
1 condition
1 sponsor
252 locations
NCT04487587
A Phase II Clinical Trial of Cediranib and Olaparib Maintenance in Advanced Recurrent Cervical Cancer
PHASE2
Active, not recruiting
79 participants
Started: Oct 9, 2018 · Completed: Mar 1, 2026
1 condition
2 sponsors
1 location
NCT03673644
Impact of Glaucoma and Visual Field Loss on Life Space
N/A
Active, not recruiting
88 participants
Started: Oct 9, 2018 · Completed: May 30, 2026
1 condition
2 sponsors
1 location
NCT06360588
Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Loss (MATCH - Subprotocol Z1G)
PHASE2
Active, not recruiting
22 participants
Started: Oct 8, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06040580
Can we Use Resting-state fMRI and CSD Fiber Tractography for Presurgical Mapping?
N/A
Active, not recruiting
150 participants
Started: Oct 8, 2018 · Completed: Dec 31, 2025
4 conditions
1 sponsor
1 location
NCT03710746
Project Health: Enhancing Effectiveness of a Dissonance-Based Obesity Prevention Program
NA
Active, not recruiting
406 participants
Started: Oct 8, 2018 · Completed: Jun 30, 2025
1 condition
2 sponsors
2 locations
NCT06105619
A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN).
PHASE2/PHASE3
Active, not recruiting
84 participants
Started: Oct 8, 2018 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT03690388
A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy
PHASE3
Active, not recruiting
187 participants
Started: Oct 5, 2018 · Completed: Jul 31, 2026
1 condition
2 sponsors
164 locations
NCT03554083
Vemurafenib, Cobimetinib, Atezolizumab, and Tiragolumab in Treating Patients With High-Risk Stage III Melanoma
PHASE2
Active, not recruiting
59 participants
Started: Oct 5, 2018 · Completed: Nov 30, 2027
6 conditions
1 sponsor
3 locations
NCT03615326
Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)
PHASE3
Active, not recruiting
738 participants
Started: Oct 5, 2018 · Completed: Nov 12, 2025
2 conditions
1 sponsor
192 locations
NCT03126630
Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma
PHASE1/PHASE2
Active, not recruiting
49 participants
Started: Oct 4, 2018 · Completed: Sep 18, 2026
1 condition
1 sponsor
33 locations
NCT03589326
A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
PHASE3
Active, not recruiting
245 participants
Started: Oct 4, 2018 · Completed: Jul 31, 2027
1 condition
1 sponsor
92 locations
NCT03543189
Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy
PHASE1/PHASE2
Active, not recruiting
44 participants
Started: Oct 3, 2018 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT03531099
Phase 3, Multicenter, Randomized Study, Evaluating the Efficacy and Tolerability of Focused HIFU (High Intensity Focused Ultrasound) Therapy Compared to Active Surveillance in Patients With Significant Low Risk Prostate Cancer
PHASE3
Active, not recruiting
108 participants
Started: Oct 2, 2018 · Completed: Oct 2, 2026
1 condition
1 sponsor
14 locations
NCT03511625
The Effects of Acthar on Synovial Inflammation in Rheumatoid Arthritis
PHASE3
Active, not recruiting
6 participants
Started: Oct 2, 2018 · Completed: Dec 3, 2024
1 condition
2 sponsors
1 location
NCT03857594
Integrative Sequencing in Germline and Hereditary Tumours
N/A
Active, not recruiting
10 participants
Started: Oct 2, 2018 · Completed: Sep 30, 2025
4 conditions
1 sponsor
1 location
NCT03595683
Pembrolizumab and EDP1503 in Advanced Melanoma
PHASE2
Active, not recruiting
8 participants
Started: Oct 2, 2018 · Completed: Nov 2, 2027
2 conditions
3 sponsors
1 location
NCT03709199
Long Term Follow up of Children Enrolled in the REDvent Study
N/A
Active, not recruiting
176 participants
Started: Oct 1, 2018 · Completed: May 1, 2026
5 conditions
1 sponsor
1 location
NCT03646357
BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function
PHASE4
Active, not recruiting
2,895 participants
Started: Oct 1, 2018 · Completed: Dec 10, 2035
3 conditions
15 sponsors
20 locations
NCT03531463
The Nordic DeltaCon Trial for Displaced Proximal Humeral Fractures in Elderly
NA
Active, not recruiting
154 participants
Started: Oct 1, 2018 · Completed: Dec 10, 2028
1 condition
2 sponsors
3 locations
NCT03716817
TetricCAD Crown Clinical Study
NA
Active, not recruiting
50 participants
Started: Oct 1, 2018 · Completed: Oct 31, 2026
3 conditions
2 sponsors
1 location
NCT03478566
Transcutaneous CO2 Monitoring at Home for Children With Neuromuscular Disease
NA
Active, not recruiting
39 participants
Started: Oct 1, 2018 · Completed: Sep 1, 2023
4 conditions
1 sponsor
1 location
NCT03693014
A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors
PHASE2
Active, not recruiting
69 participants
Started: Oct 1, 2018 · Completed: Oct 31, 2026
6 conditions
1 sponsor
10 locations
NCT03685461
AB-Intra- and Post-Operative Measures of Auditory Function
NA
Active, not recruiting
88 participants
Started: Oct 1, 2018 · Completed: Jul 31, 2026
2 conditions
1 sponsor
1 location
NCT03410420
Detection of Hypoxia in Human Thoracic Aorta Using Pimonidazole Hydrochloride
PHASE1
Active, not recruiting
40 participants
Started: Oct 1, 2018 · Completed: Aug 1, 2026
1 condition
1 sponsor
1 location
NCT03590028
An Early Real-Time Electronic Health Record Risk Algorithm for the Prevention and Treatment of Acute Kidney Injury
NA
Active, not recruiting
180 participants
Started: Oct 1, 2018 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT04514978
The Effect of Blood Donation on Hematological and Iron Indices and Detection of Autologous Blood Transfusion
NA
Active, not recruiting
48 participants
Started: Oct 1, 2018 · Completed: Jan 31, 2024
1 condition
3 sponsors
1 location
NCT03611023
Study of the Touch® Trapezo-metacarpal Prosthesis
N/A
Active, not recruiting
350 participants
Started: Oct 1, 2018 · Completed: Sep 30, 2036
2 conditions
1 sponsor
1 location
NCT03477942
Impact of Mesenchymal Stem Cells in Knee Osteoarthritis
PHASE1
Active, not recruiting
16 participants
Started: Oct 1, 2018 · Completed: Jul 31, 2026
4 conditions
2 sponsors
1 location
NCT03747159
Synergetic B-cell Immunomodulation in SLE - 2nd Study.
PHASE3
Active, not recruiting
70 participants
Started: Oct 1, 2018 · Completed: Jun 7, 2026
1 condition
3 sponsors
4 locations
NCT03641755
Olaparib + Sapacitabine in BRCA Mutant Breast Cancer
PHASE1
Active, not recruiting
10 participants
Started: Oct 1, 2018 · Completed: Oct 22, 2025
1 condition
3 sponsors
2 locations
NCT03274479
PBF-1129 in Patients With NSCLC
PHASE1
Active, not recruiting
18 participants
Started: Oct 1, 2018 · Completed: Aug 1, 2024
1 condition
2 sponsors
1 location
NCT03620773
Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes
PHASE1/PHASE2
Active, not recruiting
30 participants
Started: Oct 1, 2018 · Completed: Oct 1, 2024
12 conditions
1 sponsor
1 location
NCT03570177
Fracture Prediction by Opportunistic Screening for Osteoporosis
N/A
Active, not recruiting
173,720 participants
Started: Oct 1, 2018 · Completed: Jan 31, 2025
1 condition
1 sponsor
1 location
Previous
1
More pages
331
332
333
334
335
336
337
More pages
431
Next